EcoR1 Capital LLC 13D/13G Filings for Janux Therapeutics, Inc. (JANX)

EcoR1 Capital LLC 13D and 13G filings for Janux Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
5:53 pm
Sale		 2023-12-31 13G Janux Therapeutics, Inc.
JANX		 EcoR1 Capital LLC 0
0.000%		 -3,255,270decrease
(Position Closed)		 Filing
2023-01-20
5:32 pm
Purchase		 2023-01-10 13G Janux Therapeutics, Inc.
JANX		 EcoR1 Capital LLC 3,255,270
7.800%		 3,255,270increase
(New Position)		 Filing